Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.30 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11061615 | 0.79 | GABRA1 (0.52) | GABRA1GABRB2 | |
| SCHEMBL657769 | 0.77 | TYR (0.33) | — | |
| SCHEMBL19030702 | 0.75 | TSHR (0.37) | — | |
| SCHEMBL8389267 | 0.74 | IAPP (0.52) | GABRA1GABRB2 | |
| SCHEMBL1258491 | 0.74 | GABRA1 (0.52) | GABRA1GABRB2 | |
| SCHEMBL659662 | 0.74 | SHBG (0.33) | — | |
| SCHEMBL5785094 | 0.72 | ALDH1A1 (0.50) | GABRA1GABRB2 | |
| SCHEMBL20906311 | 0.72 | GABRA1 (0.45) | GABRA1GABRB2 | |
| SCHEMBL2050223 | 0.71 | HSP90AA1 (0.47) | GABRA1GABRB2 | |
| SCHEMBL19510859 | 0.71 | GABRA1 (0.39) | GABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8043534-B2 | An adhesive comprising a maleimide and an aromatic diene or an aromatic monoene which cure to form useful thermosetting resins for the microelectronic packaging industry; semiconcuctor dies; addition polymerization/Diels-Alder reaction; heat and acid resistance; toughness; noncracking; nondestructive | DESIGNER MOLECULES, INC. (US) | 2011-10-25 | — | — | US | disclosed |
| US-8043534-B2 | An adhesive comprising a maleimide and an aromatic diene or an aromatic monoene which cure to form useful thermosetting resins for the microelectronic packaging industry; semiconcuctor dies; addition polymerization/Diels-Alder reaction; heat and acid resistance; toughness; noncracking; nondestructive | DESIGNER MOLECULES, INC. (US) | 2011-10-25 | — | — | US | disclosed |
| US-20080075965-A1 | Maleimide compositions and methods for use thereof | DESIGNER MOLECULES, INC. | 2008-03-27 | — | — | US | disclosed |
| US-20080075965-A1 | Maleimide compositions and methods for use thereof | DESIGNER MOLECULES, INC. | 2008-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080075965-A1 | Maleimide compositions and methods for use thereof | KDM4E, MLLT1, DOT1L | GABRA1 1603/4885GABRB2 2245/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.